DANIEL EVERETT GEFFKEN
Accountancy in Waltham, MA

Board of Directors; Audit Committee, Compensation Committee at Alcobra Ltd, Part time Chief Financial Officer at Arus Biologics, Interim CFO at K2 Therapeutics, Chief Financial Officer at Sideris Pharmaceuticals, Interim Chief Financial Officer at Novira Therapeutics, Interim CFO at Bionostics, Inc, Financial Consultant at Genocea Biosciences, Interim Chief Financial Officer at Promedior, Inc, Senior Financial Advisor at Anchor Therapeutics, Strategic Advisor at Acusphere, Founder and Managing Director at Danforth Advisors, Interim Chief Financial Officer at USDS, Inc.

Biotechnology

Alcobra Ltd - Tel Aviv since May 2013 - Board of Directors; Audit Committee, Compensation Committee Arus Biologics - Grantham, New Hampshire since Mar 2013 - Part time Chief Financial Officer K2 Therapeutics - Waltham, MA since Jan 2013 - Interim CFO Sideris Pharmaceuticals - Waltham, MA since Dec 2012 - Chief Financial Officer Novira Therapeutics - Doylestown, PA since Aug 2012 - Interim Chief Financial Officer Bionostics, Inc - Devens, Massachusetts since Jun 2012 - Interim CFO Genocea Biosciences - Cambridge, MA since Jun 2012 - Financial Consultant Promedior, Inc - Massachusetts since May 2012 - Interim Chief Financial Officer Anchor Therapeutics - Cambridge, MA since Mar 2012 - Senior Financial Advisor Acusphere since Feb 2012 - Strategic Advisor Danforth Advisors - Massachusetts since Aug 2011 - Founder and Managing Director USDS, Inc. - Rockville, MD since Jul 2011 - Interim Chief Financial Officer InfoBionic, Inc. Feb 2012 - Dec 2012 - Strategic Advisor Algeta US, LLC - Cambridge, MA Mar 2012 - Nov 2012 - Senior Advisor, Finance and Operations Seaside Therapeutics Aug 2009 - Feb 2011 - Chief Operating Officer Daniel Geffken Consulting, LLC 2008 - Aug 2009 - Principal Codon Devices 2006 - 2008 - CFO Konarka Technologies 2006 - 2007 - EVP, CFO OmniSonics Medical Technologies 2003 - 2006 - SVP, CFO Transkaryotic Therapies, Inc. Jan 1997 - Apr 2003 - SVP, CFO CytoTherpeutics, Inc. 1993 - 1997 - VP, CFO MedChem Products 1989 - 1991 - Chief Financial Officer Peat Marwick 1979 - 1985 - Sr. Manager

Harvard Business School 1985 - 1987
MBA University of Pennsylvania - The Wharton School 1975 - 1979